Investing in Income Stocks to Combat Inflationary Pressure

Aug.30.2022
Investing in Income Stocks to Combat Inflationary Pressure
Investing in income stocks like Vistry (LSE: VTY) and British American Tobacco (LSE: BATS) can help combat rising inflation rates.

It is expected that the inflation rate will reach 18% next year, and I believe that income stocks are particularly attractive for my investment portfolio. However, few companies will pay enough cash to fully offset the impact of rising prices. But every little bit helps, especially when this money can be used to purchase more stocks in a volatile market.


The performance records of two companies indicate that they believe they should continue to pay large salaries during this economic storm and increase expenses thereafter.


Very inexpensive.


Housing construction company Vistry (LSE: VTY), formerly known as Bovis Homes, has a forecasted dividend yield of 9.4%. This makes it one of the largest payers in the FTSE 250 index. In comparison, the overall return rate of the index is slightly below 3%.


The flagship stock tip service, Share Advisor, of Motley Fool UK has just released the top six stocks that their popular analysts believe are the best buys for investors currently. While timing isn't everything, their average return on previously selected stocks suggests that getting their best ideas early is worthwhile.


Learn more.


In my opinion, there are even more reasons to like this company. Vistry has a strong track record of increasing their annual dividends paid to shareholders. This indicates a healthy and well-managed business, which is exactly the kind of company I want to have in my investment portfolio.


Is it risky to buy from builders during an economic downturn? Well, it's true that the industry is cyclical. There are certainly signs that the real estate market is beginning to decline. The Royal Institution of Chartered Surveyors in the UK recently stated that there are fewer people looking to buy homes, which is starting to affect housing prices.


Despite this, in terms of valuation, Vistry stocks can now be purchased at a level close to their historical low point. Considering the company's reported outperformance in the first half of 2022, a P/E ratio of just 5 seems very cheap. It's no wonder the company has been buying back its own stocks recently.


Is the risk worth the reward here? I believe it might be, although to be on the safe side, I would not hesitate to diversify my investment portfolio.


Monster's Share of Revenue


On my list of potential income shares to purchase is British American Tobacco (LSE: BATS). Like Vistry, the FTSE 100 giant offers an attractive dividend flow. Currently, owning the stock would entitle me to a yield of 6.7%. This is certainly not as generous as the housebuilder mentioned earlier, but it's enough to help ease the pain of rising prices.


Similarly to Vistry, BATS also has an impressive record in improving payments (although not flawless). This is partially due to the consistency in its profits. The addictive nature of its products means that the company can be fairly certain of how many cigarette packs it will sell each year, at least compared to other consumer stocks.


Obviously, no dividend stream can be guaranteed. People also need to consider that tobacco consumption has been on a long-term downward trend and the industry is always susceptible to regulatory interference. Although I am highly focused on building long-term wealth, I do recognize that the stock price of British and American Tobacco has already risen by 25% in 2022.


Returning to the topic, the valuation of this stock is still at nine times the expected earnings. Therefore, even if the momentum does slow down in the coming months, it is difficult to believe that the stock price of British American Tobacco will collapse.


Why this £5 stock could soar: Are you searching for growth stocks in the UK? If so, get this free, no-obligation report while it's still available. You'll discover what we believe to be one of the fastest-growing stocks of the next decade...and this company's performance is indeed impressive. In 2019, it returned £150 million to its shareholders through buybacks and dividends. We believe its financials are as solid as anything we've seen.


Since 2016, the company has experienced a 31% increase in annual revenue. As of March 2020, one of its senior directors holds 25,000 shares valued at £90,259. The company's operating cash flow has also grown by 47%.


Translation: Statement


This article is compiled from third-party information and is intended solely for exchange and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is solely intended for industry-related exchange and research.


Due to limitations in translation ability, the compiled article may not fully express the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please kindly contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
HM Revenue & Customs (HMRC) has officially confirmed that the UK will implement a Vaping Products Duty (VPD) and Vaping Duty Stamps (VDS) scheme from October 1, 2026. The duty will apply to all vaping liquids at a flat rate of £2.20 per 10ml. Businesses must register for approval starting April 1, 2026. The stamps scheme will take effect in October 2026 with a six-month grace period, after which, from April 2027, unstamped products will be prohibited from sale.
Oct.02 by 2FIRSTS.ai
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.
Nov.12 by 2FIRSTS.ai
Czech Republic to Tighten E-Cigarette Rules in December, Ban Candy Flavours and Cannabinoids
Czech Republic to Tighten E-Cigarette Rules in December, Ban Candy Flavours and Cannabinoids
Czech Republic will tighten regulations on the sale and labelling of e-cigarettes from December. Manufacturers will have seven months to sell existing stock, after which candy-flavoured or cannabinoid-containing e-cigarettes will be banned. A survey by the National Institute of Public Health (SZÚ) found that nearly 14% of the population used e-cigarettes in 2024 — almost triple the rate five years earlier.
Nov.18 by 2FIRSTS.ai
 Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
Australia NSW Police Crack Down on Illicit Tobacco Syndicate Under Strike Force Franklin
NSW Police, together with NSW Health and the Australian Border Force, seized more than 18,000 vapes, 1.9 million cigarettes, 74kg of loose-leaf tobacco and five unregistered firearms during a week of action under Strike Force Franklin. Four people were charged following coordinated raids on the Far North Coast. Police said the operation targeted organised crime networks profiting from illicit tobacco sales, with an estimated street value exceeding $2.35 million(1.54 million US dollars)..
Nov.03 by 2FIRSTS.ai
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
China’s e-cigarette maker iMiracle, parent company of the Elf Bar brand, has agreed to halt sales of all flavored vaping products in California as part of a settlement with Altria Group’s e-cigarette unit, NJOY LLC, marking the end of a nearly two-year legal dispute.
Oct.13
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai